{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:02:01Z","timestamp":1775181721230,"version":"3.50.1"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Society for the Promotion of Research in Experimental Neurology, Vienna, Austria","award":["Society for the Promotion of Research in Experimental Neurology, Vienna, Austria"],"award-info":[{"award-number":["Society for the Promotion of Research in Experimental Neurology, Vienna, Austria"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00702-024-02794-y","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:01:55Z","timestamp":1718359315000},"page":"999-1012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pathomechanisms of behavioral abnormalities in Huntington disease: an update"],"prefix":"10.1007","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"2794_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1176\/appi.neuropsych.20220033","volume":"35","author":"S Abdollah Zadegan","year":"2023","unstructured":"Abdollah Zadegan S, Coco HM, Reddy KS, Anderson KM, Teixeira AL, Stimming EF (2023) Frequency and pathophysiology of apathy in Huntington disease: a systematic review and meta-analysis. J Neuropsychiatry Clin Neurosci 35:121\u2013132","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2794_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3233\/JHD-190361","volume":"8","author":"J Adrissi","year":"2019","unstructured":"Adrissi J, Nadkarni NA, Gausche E, Bega D (2019) Electroconvulsive therapy (ECT) for refractory psychiatric symptoms in Huntington\u2019s disease: a case series and review of the literature. J Huntingtons Dis 8:291\u2013300","journal-title":"J Huntingtons Dis"},{"key":"2794_CR3","first-page":"197","volume":"96","author":"KE Anderson","year":"2005","unstructured":"Anderson KE, Marshall FJ (2005) Behavioral symptoms associated with Huntington\u2019s disease. Adv Neurol 96:197\u2013208","journal-title":"Adv Neurol"},{"key":"2794_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1586\/ern.11.12","volume":"11","author":"PA Arnett","year":"2011","unstructured":"Arnett PA, Strober LB (2011) Cognitive and neurobehavioral features in multiple sclerosis. Expert Rev Neurother 11:411\u2013424","journal-title":"Expert Rev Neurother"},{"key":"2794_CR5","doi-asserted-by":"crossref","unstructured":"Arnoux I, Willam M, Griesche N, Krummeich J, Watari H, Offermann N, Weber S, Narayan Dey P, Chen C, Monteiro O, Buettner S, Meyer K, Bano D, Radyushkin K, Langston R, Lambert JJ, Wanker E, Methner A, Krauss S, Schweiger S, Stroh A (2018) Metformin reverses early cortical network dysfunction and behavior changes in Huntington\u2019s disease. Elife 7:e38744","DOI":"10.7554\/eLife.38744"},{"key":"2794_CR6","doi-asserted-by":"crossref","unstructured":"Askeland G, Rodinova M, \u0160tufkov\u00e1 H, Dosoudilova Z, Baxa M, Smatlikova P, Bohuslavova B, Klempir J, Nguyen TD, Kusnierczyk A, Bj\u00f8r\u00e5s M, Klungland A, Hansikova H, Ellederova Z, Eide L (2018) A transgenic minipig model of Huntington\u2019s disease shows early signs of behavioral and molecular pathologies. Dis Model Mech 11:dmm035949","DOI":"10.1242\/dmm.035949"},{"key":"2794_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nicl.2018.03.033","volume":"19","author":"V Baake","year":"2018","unstructured":"Baake V, Coppen EM, van Duijn E, Dumas EM, van den Bogaard SJA, Scahill RI, Johnson H, Leavitt B, Durr A, Tabrizi SJ, Craufurd D, Roos RAC (2018) Apathy and atrophy of subcortical brain structures in Huntington\u2019s disease: a two-year follow-up study. Neuroimage Clin 19:66\u201370","journal-title":"Neuroimage Clin"},{"key":"2794_CR8","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R, Wild EJ, Tabrizi SJ (2015) Huntington disease. Nat Rev Dis Primers 1:15005","journal-title":"Nat Rev Dis Primers"},{"key":"2794_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000091523","volume":"21","author":"S Baudic","year":"2006","unstructured":"Baudic S, Maison P, Dolbeau G, Boiss\u00e9 MF, Bartolomeo P, Dalla Barba G, Traykov L, Bachoud-L\u00e9vi AC (2006) Cognitive impairment related to apathy in early Huntington\u2019s disease. Dement Geriatr Cogn Disord 21:316\u2013321","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2794_CR10","doi-asserted-by":"crossref","unstructured":"Baxa M, Levinska B, Skrivankova M, Pokorny M, Juhasova J, Klima J, Klempir J, Motli KJ, Juhas S, Ellederova Z (2019) Longitudinal study revealing motor, cognitive and behavioral decline in a transgenic minipig model of Huntington\u2019s disease. Dis Model Mech 13:dmm041293","DOI":"10.1242\/dmm.041293"},{"key":"2794_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.biopsych.2006.04.034","volume":"61","author":"LJ Beglinger","year":"2007","unstructured":"Beglinger LJ, Langbehn DR, Duff K, Stierman L, Black DW, Nehl C, Anderson K, Penziner E, Paulsen JS (2007) Probability of obsessive and compulsive symptoms in Huntington\u2019s disease. Biol Psychiatry 61:415\u2013418","journal-title":"Biol Psychiatry"},{"key":"2794_CR12","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.4088\/JCP.v69n1111","volume":"69","author":"LJ Beglinger","year":"2008","unstructured":"Beglinger LJ, Paulsen JS, Watson DB, Wang C, Duff K, Langbehn DR, Moser DJ, Paulson HL, Aylward EH, Carlozzi NE, Queller S, Stout JC (2008) Obsessive and compulsive symptoms in prediagnosed Huntington\u2019s disease. J Clin Psychiatry 69:1758\u20131765","journal-title":"J Clin Psychiatry"},{"key":"2794_CR13","doi-asserted-by":"publisher","first-page":"e12891","DOI":"10.1111\/nan.12891","volume":"49","author":"S Bergh","year":"2023","unstructured":"Bergh S, Gabery S, Tonetto S, Kirik D, Peters\u00e9n \u00c5, Cheong RY (2023) Effects of mutant huntingtin in oxytocin neurons on non-motor features of Huntington\u2019s disease. Neuropathol Appl Neurobiol 49:e12891","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2794_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2174\/1570159X21666230216104621","volume":"21","author":"SA Bhat","year":"2023","unstructured":"Bhat SA, Ahamad S, Dar NJ, Siddique YH, Nazir A (2023) The emerging landscape of natural small-molecule therapeutics for Huntington\u2019s disease. Curr Neuropharmacol 21:867\u2013889","journal-title":"Curr Neuropharmacol"},{"key":"2794_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00415-023-11982-x","volume":"271","author":"H Bilal","year":"2024","unstructured":"Bilal H, Harding IH, Stout JC (2024) The relationship between disease-specific psychosocial stressors and depressive symptoms in Huntington\u2019s disease. J Neurol 271:289\u2013299","journal-title":"J Neurol"},{"key":"2794_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brainres.2004.01.021","volume":"1005","author":"VJ Bolivar","year":"2004","unstructured":"Bolivar VJ, Manley K, Messer A (2004) Early exploratory behavior abnormalities in R6\/1 Huntington\u2019s disease transgenic mice. Brain Res 1005:29\u201335","journal-title":"Brain Res"},{"key":"2794_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/0361-9230(94)00242-S","volume":"36","author":"CV Borlongan","year":"1995","unstructured":"Borlongan CV, Koutouzis TK, Randall TS, Freeman TB, Cahill DW, Sanberg PR (1995) Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats. Brain Res Bull 36:549\u2013556","journal-title":"Brain Res Bull"},{"key":"2794_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1176\/appi.neuropsych.14030051","volume":"27","author":"JA Bouwens","year":"2015","unstructured":"Bouwens JA, van Duijn E, van der Mast RC, Roos RA, Giltay EJ (2015) Irritability in a prospective cohort of Huntington\u2019s disease mutation carriers. J Neuropsychiatry Clin Neurosci 27:206\u2013212","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2794_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.brainresbull.2011.07.021","volume":"88","author":"KR Bowles","year":"2012","unstructured":"Bowles KR, Brooks SP, Dunnett SB, Jones L (2012) Gene expression and behaviour in mouse models of HD. Brain Res Bull 88:276\u2013284","journal-title":"Brain Res Bull"},{"key":"2794_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.brainresbull.2010.05.003","volume":"88","author":"S Brooks","year":"2012","unstructured":"Brooks S, Higgs G, Jones L, Dunnett SB (2012a) Longitudinal analysis of the behavioural phenotype in HdhQ92 Huntington\u2019s disease knock-in mice. Brain Res Bull 88:148\u2013155","journal-title":"Brain Res Bull"},{"key":"2794_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.brainresbull.2011.10.002","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Jones L, Dunnett SB (2012b) Comparative analysis of pathology and behavioural phenotypes in mouse models of Huntington\u2019s disease. Brain Res Bull 88:81\u201393","journal-title":"Brain Res Bull"},{"key":"2794_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fnhum.2016.00317","volume":"10","author":"KD Bunner","year":"2016","unstructured":"Bunner KD, Rebec GV (2016) Corticostriatal dysfunction in Huntington\u2019s disease: the basics. Front Hum Neurosci 10:317","journal-title":"Front Hum Neurosci"},{"key":"2794_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3233\/JHD-190352","volume":"9","author":"M Cabanas","year":"2020","unstructured":"Cabanas M, Piquemal M, Pistono C, Arnaud S, Rakesh D, Poinama E, Guillou JL, Garret M, Cho YH (2020) Correlations between mutant huntingtin aggregates and behavioral changes in R6\/1 mice. J Huntingtons Dis 9:33\u201345","journal-title":"J Huntingtons Dis"},{"key":"2794_CR24","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/bs.irn.2017.05.004","volume":"134","author":"F Cardoso","year":"2017","unstructured":"Cardoso F (2017) Nonmotor symptoms in Huntington disease. Int Rev Neurobiol 134:1397\u20131408","journal-title":"Int Rev Neurobiol"},{"key":"2794_CR25","unstructured":"Caron NS, Wright GEB, Hayden MR (1993) Huntington disease. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (eds) GeneReviews\u00ae, 2020\/06\/11 Edition. University of Washington, Seattle Seattle (WA), https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1305\/ - updated 2020 Jun 11"},{"key":"2794_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1750-1326-6-59","volume":"6","author":"JB Carroll","year":"2011","unstructured":"Carroll JB, Southwell AL, Graham RK, Lerch JP, Ehrnhoefer DE, Cao LP, Zhang WN, Deng Y, Bissada N, Henkelman RM, Hayden MR (2011) Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease. Mol Neurodegener 6:59","journal-title":"Mol Neurodegener"},{"key":"2794_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2967\/jnumed.118.210393","volume":"60","author":"J Ceccarini","year":"2019","unstructured":"Ceccarini J, Ahmad R, Van de Vliet L, Casteels C, Vandenbulcke M, Vandenberghe W, Van Laere K (2019) Behavioral symptoms in Premanifest Huntington disease correlate with reduced frontal CB(1)R levels. J Nucl Med 60:115\u2013121","journal-title":"J Nucl Med"},{"key":"2794_CR28","doi-asserted-by":"publisher","first-page":"105166","DOI":"10.1016\/j.neubiorev.2023.105166","volume":"149","author":"ML Clark","year":"2023","unstructured":"Clark ML, Abimanyi-Ochom J, Le H, Long B, Orr C, Khanh-Dao Le L (2023) A systematic review and meta-analysis of depression and apathy frequency in adult-onset Huntington\u2019s disease. Neurosci Biobehav Rev 149:105166","journal-title":"Neurosci Biobehav Rev"},{"key":"2794_CR29","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1523\/JNEUROSCI.1172-22.2023","volume":"43","author":"S Conde-Berriozabal","year":"2023","unstructured":"Conde-Berriozabal S, Garc\u00eda-Gilabert L, Garc\u00eda-Garc\u00eda E, Sitj\u00e0-Roqueta L, L\u00f3pez-Gil X, Mu\u00f1oz-Moreno E, Boutagouga Boudjadja M, Soria G, Rodr\u00edguez MJ, Alberch J, Masana M (2023) M2 cortex circuitry and sensory-induced behavioral alterations in Huntington\u2019s disease: role of superior colliculus. J Neurosci 43:3379\u20133390","journal-title":"J Neurosci"},{"key":"2794_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1176\/appi.neuropsych.21070191","volume":"35","author":"MH Connors","year":"2023","unstructured":"Connors MH, Teixeira-Pinto A, Loy CT (2023) Apathy and depression in Huntington\u2019s disease: distinct longitudinal trajectories and clinical correlates. J Neuropsychiatry Clin Neurosci 35:69\u201376","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2794_CR31","doi-asserted-by":"publisher","first-page":"e28409","DOI":"10.1371\/journal.pone.0028409","volume":"6","author":"RM Cowin","year":"2011","unstructured":"Cowin RM, Bui N, Graham D, Green JR, Grueninger S, Yuva-Paylor LA, Syed AU, Weiss A, Paylor R (2011) Onset and progression of behavioral and molecular phenotypes in a novel congenic R6\/2 line exhibiting intergenerational CAG repeat stability. PLoS ONE 6:e28409","journal-title":"PLoS ONE"},{"key":"2794_CR32","first-page":"219","volume":"14","author":"D Craufurd","year":"2001","unstructured":"Craufurd D, Thompson JC, Snowden JS (2001) Behavioral changes in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol 14:219\u2013226","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"2794_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/JHD-180339","volume":"8","author":"T Cronin","year":"2019","unstructured":"Cronin T, Rosser A, Massey T (2019) Clinical presentation and features of juvenile-onset Huntington\u2019s disease: a systematic review. J Huntingtons Dis 8:171\u2013179","journal-title":"J Huntingtons Dis"},{"key":"2794_CR34","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.1007\/s12035-018-0890-6","volume":"55","author":"VS da Fons\u00eaca","year":"2018","unstructured":"da Fons\u00eaca VS, da Silva Colla AR, de Paula Nascimento-Castro C, Pl\u00e1cido E, Rosa JM, Farina M, Gil-Mohapel J, Rodrigues ALS, Brocardo PS (2018) Brain-derived neurotrophic factor prevents depressive-like behaviors in early-symptomatic YAC128 Huntington\u2019s disease mice. Mol Neurobiol 55:7201\u20137215","journal-title":"Mol Neurobiol"},{"key":"2794_CR35","doi-asserted-by":"publisher","first-page":"110776","DOI":"10.1016\/j.pnpbp.2023.110776","volume":"126","author":"MC Davis","year":"2023","unstructured":"Davis MC, Hill AT, Fitzgerald PB, Bailey NW, Sullivan C, Stout JC, Hoy KE (2023) Medial prefrontal transcranial alternating current stimulation for apathy in Huntington\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 126:110776","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2794_CR37","doi-asserted-by":"crossref","unstructured":"de Paula Nascimento-Castro C, Winkelmann-Duarte C, Mancini EC, Welter G, Pl\u00e1cido PG, Farina E, Gil-Mohapel M, Rodrigues J, de Bem ALS, Brocardo AF PS (2022) Temporal characterization of behavioral and hippocampal dysfunction in the YAC128 mouse model of Huntington\u2019s disease. Biomedicines 10:1433","DOI":"10.3390\/biomedicines10061433"},{"key":"2794_CR36","doi-asserted-by":"publisher","first-page":"101965","DOI":"10.1016\/j.nicl.2019.101965","volume":"24","author":"AE De Paepe","year":"2019","unstructured":"De Paepe AE, Sierpowska J, Garcia-Gorro C, Martinez-Horta S, Perez-Perez J, Kulisevsky J, Rodriguez-Dechicha N, Vaquer I, Subira S, Calopa M, Mu\u00f1oz E, Santacruz P, Ruiz-Idiago J, Mareca C, de Diego-Balaguer R, Camara E (2019) White matter cortico-striatal tracts predict apathy subtypes in Huntington\u2019s disease. Neuroimage Clin 24:101965","journal-title":"Neuroimage Clin"},{"key":"2794_CR38","first-page":"e47526","volume":"15","author":"H Dhingra","year":"2023","unstructured":"Dhingra H, Gaidhane SA (2023) Huntington\u2019s disease: understanding its novel drugs and treatments. Cureus 15:e47526","journal-title":"Cureus"},{"key":"2794_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cortex.2017.04.001","volume":"92","author":"DJF Dom\u00ednguez","year":"2017","unstructured":"Dom\u00ednguez DJF, Poudel G, Stout JC, Gray M, Chua P, Borowsky B, Egan GF, Georgiou-Karistianis N (2017) Longitudinal changes in the fronto-striatal network are associated with executive dysfunction and behavioral dysregulation in Huntington\u2019s disease: 30 months IMAGE-HD data. Cortex 92:139\u2013149","journal-title":"Cortex"},{"key":"2794_CR40","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/cercor\/bhz245","volume":"30","author":"EJ Donzis","year":"2020","unstructured":"Donzis EJ, Estrada-S\u00e1nchez AM, Indersmitten T, Oikonomou K, Tran CH, Wang C, Latifi S, Golshani P, Cepeda C, Levine MS (2020) Cortical network dynamics is altered in mouse models of Huntington\u2019s disease. Cereb Cortex 30:2372\u20132388","journal-title":"Cereb Cortex"},{"key":"2794_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","volume":"178","author":"JL Dorner","year":"2007","unstructured":"Dorner JL, Miller BR, Barton SJ, Brock TJ, Rebec GV (2007) Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington\u2019s disease. Behav Brain Res 178:90\u201397","journal-title":"Behav Brain Res"},{"key":"2794_CR42","doi-asserted-by":"crossref","unstructured":"Duyckaerts C, Joyon N, D\u00fcrr A (2014) Neurodegenerative diseases linked to trinucleotide repeats. In: Kovacs G (ed) Neuropathology of neurodegenerative diseases: a practical guide. Cambridge University Press Cambridge, pp 195\u2013208","DOI":"10.1017\/CBO9781107588660.011"},{"key":"2794_CR43","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S2215-0366(16)30144-4","volume":"3","author":"CM Eddy","year":"2016","unstructured":"Eddy CM, Parkinson EG, Rickards HE (2016) Changes in mental state and behaviour in Huntington\u2019s disease. Lancet Psychiatry 3:1079\u20131086","journal-title":"Lancet Psychiatry"},{"key":"2794_CR44","doi-asserted-by":"publisher","unstructured":"Ekwudo MN, Gubert C, Hannan AJ (2024) The microbiota-gut-brain axis in Huntington\u2019s disease: pathogenic mechanisms and therapeutic targets. FEBS J. doi:https:\/\/doi.org\/10.1111\/febs.17102","DOI":"10.1111\/febs.17102"},{"key":"2794_CR45","doi-asserted-by":"publisher","first-page":"106087","DOI":"10.1016\/j.parkreldis.2024.106087","volume":"123","author":"J En-Hua Wang","year":"2024","unstructured":"En-Hua Wang J, Simon NG, Brownstein MJ, Maibach HT, Maibach J, Anderson KE (2024) The utility of the irritability scale in Huntington\u2019s disease patients with evidence of irritability or aggression. Parkinsonism Relat Disord 123:106087","journal-title":"Parkinsonism Relat Disord"},{"key":"2794_CR46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/brain.2017.0538","volume":"8","author":"FA Espinoza","year":"2018","unstructured":"Espinoza FA, Turner JA, Vergara VM, Miller RL, Mennigen E, Liu J, Misiura MB, Ciarochi J, Johnson HJ, Long JD, Bockholt HJ, Magnotta VA, Paulsen JS, Calhoun VD (2018) Whole-brain connectivity in a large study of Huntington\u2019s disease gene mutation carriers and healthy controls. Brain Connect 8:166\u2013178","journal-title":"Brain Connect"},{"key":"2794_CR47","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1093\/brain\/awad275","volume":"146","author":"C Estevez-Fraga","year":"2023","unstructured":"Estevez-Fraga C, Altmann A, Parker CS, Scahill RI, Costa B, Chen Z, Manzoni C, Zarkali A, Durr A, Roos RAC, Landwehrmeyer B, Leavitt BR, Rees G, Tabrizi SJ, McColgan P (2023) Genetic topography and cortical cell loss in Huntington\u2019s disease link development and neurodegeneration. Brain 146:4532\u20134546","journal-title":"Brain"},{"key":"2794_CR48","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1523\/JNEUROSCI.2812-14.2015","volume":"35","author":"AM Estrada-S\u00e1nchez","year":"2015","unstructured":"Estrada-S\u00e1nchez AM, Burroughs CL, Cavaliere S, Barton SJ, Chen S, Yang XW, Rebec GV (2015) Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington\u2019s disease. J Neurosci 35:4440\u20134451","journal-title":"J Neurosci"},{"key":"2794_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mds.28855","volume":"37","author":"JJ Ferreira","year":"2022","unstructured":"Ferreira JJ, Rodrigues FB, Duarte GS, Mestre TA, Bachoud-Levi AC, Bentivoglio AR, Burgunder JM, Cardoso F, Claassen DO, Landwehrmeyer GB, Kulisevsky J, Nirenberg MJ, Rosser A, Roth J, Seppi K, Slawek J, Furr-Stimming E, Tabrizi SJ, Walker FO, Vandenberghe W, Costa J, Sampaio C (2022) An MDS evidence-based review on treatments for Huntington\u2019s disease. Mov Disord 37:25\u201335","journal-title":"Mov Disord"},{"key":"2794_CR50","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3233\/JHD-200422","volume":"9","author":"A Ferreira-Correia","year":"2020","unstructured":"Ferreira-Correia A, Krause A, Anderson DG (2020) The neuropsychiatry of Huntington disease-like 2: a comparison with Huntington\u2019s disease. J Huntingtons Dis 9:325\u2013334","journal-title":"J Huntingtons Dis"},{"key":"2794_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1176\/appi.neuropsych.17080173","volume":"30","author":"NE Fritz","year":"2018","unstructured":"Fritz NE, Boileau NR, Stout JC, Ready R, Perlmutter JS, Paulsen JS, Quaid K, Barton S, McCormack MK, Perlman SL, Carlozzi NE (2018) Relationships among apathy, health-related quality of life, and function in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 30:194\u2013201","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2794_CR52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/jpm13030385","volume":"13","author":"X Garc\u00eda-Gonz\u00e1lez","year":"2023","unstructured":"Garc\u00eda-Gonz\u00e1lez X, Cubo E, Sim\u00f3n-Vicente L, Mariscal N, Alcaraz R, Aguado L, Rivadeneyra-Posadas J, Sanz-Solas A, Saiz-Rodr\u00edguez M (2023) Pharmacogenetics in the treatment of Huntington\u2019s disease: review and future perspectives. J Pers Med 13:385","journal-title":"J Pers Med"},{"key":"2794_CR53","doi-asserted-by":"publisher","first-page":"101900","DOI":"10.1016\/j.nicl.2019.101900","volume":"23","author":"C Garcia-Gorro","year":"2019","unstructured":"Garcia-Gorro C, Llera A, Martinez-Horta S, Perez-Perez J, Kulisevsky J, Rodriguez-Dechicha N, Vaquer I, Subira S, Calopa M, Mu\u00f1oz E, Santacruz P, Ruiz-Idiago J, Mareca C, Beckmann CF, de Diego-Balaguer R, Camara E (2019) Specific patterns of brain alterations underlie distinct clinical profiles in Huntington\u2019s disease. Neuroimage Clin 23:101900","journal-title":"Neuroimage Clin"},{"key":"2794_CR54","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.brainresbull.2011.10.001","volume":"88","author":"P Giles","year":"2012","unstructured":"Giles P, Elliston L, Higgs GV, Brooks SP, Dunnett SB, Jones L (2012) Longitudinal analysis of gene expression and behaviour in the HdhQ150 mouse model of Huntington\u2019s disease. Brain Res Bull 88:199\u2013209","journal-title":"Brain Res Bull"},{"key":"2794_CR55","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1191\/1352458505ms1153oa","volume":"11","author":"Y Goverover","year":"2005","unstructured":"Goverover Y, Chiaravalloti N, DeLuca J (2005) The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Mult Scler 11:203\u2013212","journal-title":"Mult Scler"},{"key":"2794_CR56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3233\/JHD-150160","volume":"4","author":"S Gregory","year":"2015","unstructured":"Gregory S, Scahill RI, Seunarine KK, Stopford C, Zhang H, Zhang J, Orth M, Durr A, Roos RA, Langbehn DR, Long JD, Johnson H, Rees G, Tabrizi SJ, Craufurd D (2015) Neuropsychiatry and white matter microstructure in Huntington\u2019s disease. J Huntingtons Dis 4:239\u2013249","journal-title":"J Huntingtons Dis"},{"key":"2794_CR57","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1006\/exnr.2000.7384","volume":"163","author":"KL Haik","year":"2000","unstructured":"Haik KL, Shear DA, Schroeder U, Sabel BA, Dunbar GL (2000) Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington\u2019s disease. Exp Neurol 163:430\u2013439","journal-title":"Exp Neurol"},{"key":"2794_CR58","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","volume":"14","author":"O Hansson","year":"2001","unstructured":"Hansson O, Guatteo E, Mercuri NB, Bernardi G, Li XJ, Castilho RF, Brundin P (2001) Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the Huntington gene. Eur J Neurosci 14:1492\u20131504","journal-title":"Eur J Neurosci"},{"key":"2794_CR59","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/jnnp-2019-322038","volume":"91","author":"KL Harris","year":"2020","unstructured":"Harris KL, Kuan WL, Mason SL, Barker RA (2020) Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington\u2019s disease (Enroll-HD). J Neurol Neurosurg Psychiatry 91:622\u2013630","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2794_CR60","doi-asserted-by":"publisher","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen T, Lehtim\u00e4ki K, Vartiainen N, Puoliv\u00e4li J, Hendricks SJ, Glaser JR, Bradaia A, Wadel K, Touller C, Kontkanen O, Yrj\u00e4nheikki JM, Buisson B, Howland D, Beaumont V, Munoz-Sanjuan I, Park LC (2012) Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS ONE 7:e50717","journal-title":"PLoS ONE"},{"key":"2794_CR61","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1017\/S1355617722000364","volume":"29","author":"RK Hendel","year":"2023","unstructured":"Hendel RK, Hellem MNN, Hjermind LE, Nielsen JE, Vogel A (2023) On the association between apathy and deficits of social cognition and executive functions in Huntington\u2019s disease. J Int Neuropsychol Soc 29:369\u2013376","journal-title":"J Int Neuropsychol Soc"},{"key":"2794_CR62","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1080\/13803395.2015.1073226","volume":"37","author":"DC Hergert","year":"2015","unstructured":"Hergert DC, Sanchez-Ramos J, Cimino CR (2015) Examining Huntington\u2019s disease patient and informant concordance on frontally mediated behaviors. J Clin Exp Neuropsychol 37:981\u2013987","journal-title":"J Clin Exp Neuropsychol"},{"key":"2794_CR63","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1601-183X.2007.00350.x","volume":"7","author":"A Hodges","year":"2008","unstructured":"Hodges A, Hughes G, Brooks S, Elliston L, Holmans P, Dunnett SB, Jones L (2008) Brain gene expression correlates with changes in behavior in the R6\/1 mouse model of Huntington\u2019s disease. Genes Brain Behav 7:288\u2013299","journal-title":"Genes Brain Behav"},{"key":"2794_CR64","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3233\/JHD-190351","volume":"8","author":"R Hoffmann","year":"2019","unstructured":"Hoffmann R, Schr\u00f6der N, Br\u00fcne M, von Hein S, Saft C (2019) Obsessive-compulsive symptoms are less common in Huntington\u2019s disease than reported earlier. J Huntingtons Dis 8:493\u2013500","journal-title":"J Huntingtons Dis"},{"key":"2794_CR65","first-page":"317","volume":"26","author":"G Huntington","year":"1872","unstructured":"Huntington G (1872) On chorea. Med Surg Report 26:317\u2013321. https:\/\/neuro.psychiatryonline.org\/doi\/pdf\/310.1176\/jnp.1115.1171.1109","journal-title":"Med Surg Report"},{"key":"2794_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1155\/1992\/926819","volume":"5","author":"DH Jacobs","year":"1992","unstructured":"Jacobs DH, Huber SJ (1992) The role of the caudate in nonmotor behaviors in Huntington\u2019s disease. Behav Neurol 5:205\u2013214","journal-title":"Behav Neurol"},{"key":"2794_CR67","doi-asserted-by":"publisher","unstructured":"Jellinger KA (2024) The pathobiology of depression in Huntington\u2019s disease: an unresolved puzzle. J Neural Transm (Vienna). doi:https:\/\/doi.org\/10.1007\/s00702-00024-02750-w","DOI":"10.1007\/s00702-00024-02750-w"},{"key":"2794_CR68","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.nbd.2015.02.006","volume":"76","author":"L Jiang","year":"2015","unstructured":"Jiang L, O\u2019Leary C, Kim HA, Parish CL, Massalas J, Waddington JL, Ehrlich ME, Sch\u00fctz G, Gantois I, Lawrence AJ, Drago J (2015) Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells. Neurobiol Dis 76:137\u2013158","journal-title":"Neurobiol Dis"},{"key":"2794_CR69","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/mds.27980","volume":"35","author":"P Julayanont","year":"2020","unstructured":"Julayanont P, Heilman KM, McFarland NR (2020) Early-motor phenotype relates to neuropsychiatric and cognitive disorders in Huntington\u2019s disease. Mov Disord 35:781\u2013788","journal-title":"Mov Disord"},{"key":"2794_CR70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12264-009-0513-3","volume":"25","author":"H Kalonia","year":"2009","unstructured":"Kalonia H, Kumar P, Kumar A, Nehru B (2009) Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status. Neurosci Bull 25:343\u2013352","journal-title":"Neurosci Bull"},{"key":"2794_CR71","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/JHD-200397","volume":"9","author":"NE Karagas","year":"2020","unstructured":"Karagas NE, Rocha NP, Stimming EF (2020) Irritability in Huntington\u2019s disease. J Huntingtons Dis 9:107\u2013113","journal-title":"J Huntingtons Dis"},{"key":"2794_CR72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.genhosppsych.2007.11.005","volume":"30","author":"EM Kingma","year":"2008","unstructured":"Kingma EM, van Duijn E, Timman R, van der Mast RC, Roos RA (2008) Behavioural problems in Huntington\u2019s disease using the Problem behaviours Assessment. Gen Hosp Psychiatry 30:155\u2013161","journal-title":"Gen Hosp Psychiatry"},{"key":"2794_CR73","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000501616","volume":"19","author":"M Kronenbuerger","year":"2019","unstructured":"Kronenbuerger M, Hua J, Bang JYA, Ultz KE, Miao X, Zhang X, Pekar JJ, van Zijl PCM, Duan W, Margolis RL, Ross CA (2019) Differential changes in functional connectivity of striatum-prefrontal and striatum-motor circuits in Premanifest Huntington\u2019s disease. Neurodegener Dis 19:78\u201387","journal-title":"Neurodegener Dis"},{"key":"2794_CR74","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1089\/jmf.2008.0028","volume":"12","author":"P Kumar","year":"2009","unstructured":"Kumar P, Kumar A (2009) Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington\u2019s disease. J Med Food 12:591\u2013600","journal-title":"J Med Food"},{"key":"2794_CR75","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","volume":"21","author":"GA Laforet","year":"2001","unstructured":"Laforet GA, Sapp E, Chase K, McIntyre C, Boyce FM, Campbell M, Cadigan BA, Warzecki L, Tagle DA, Reddy PH, Cepeda C, Calvert CR, Jokel ES, Klapstein GJ, Ariano MA, Levine MS, DiFiglia M, Aronin N (2001) Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington\u2019s disease. J Neurosci 21:9112\u20139123","journal-title":"J Neurosci"},{"key":"2794_CR76","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/JHD-150166","volume":"4","author":"A Lenka","year":"2015","unstructured":"Lenka A, Kamble NL, Sowmya V, Jhunjhunwala K, Yadav R, Netravathi M, Kandasamy M, Moily NS, Purushottam M, Jain S, Pal PK (2015) Determinants of onset of Huntington\u2019s disease with behavioral symptoms: insight from 92 patients. J Huntingtons Dis 4:319\u2013324","journal-title":"J Huntingtons Dis"},{"key":"2794_CR77","first-page":"1865","volume":"275","author":"K Littin","year":"2008","unstructured":"Littin K, Acevedo A, Browne W, Edgar J, Mendl M, Owen D, Sherwin C, W\u00fcrbel H, Nicol C (2008) Towards humane end points: behavioural changes precede clinical signs of disease in a Huntington\u2019s disease model. Proc Biol Sci 275:1865\u20131874","journal-title":"Proc Biol Sci"},{"key":"2794_CR78","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1556\/ABiol.60.2009.4.3","volume":"60","author":"A Luk\u00e1cs","year":"2009","unstructured":"Luk\u00e1cs A, Szab\u00f3 A, Papp A, Vez\u00e9r T (2009) Altered open field behavior in rats induced by acute administration of 3-nitropropionic acid: possible glutamatergic and dopaminergic involvement. Acta Biol Hung 60:359\u2013367","journal-title":"Acta Biol Hung"},{"key":"2794_CR79","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2016.02.008","volume":"25","author":"S Martinez-Horta","year":"2016","unstructured":"Martinez-Horta S, Perez-Perez J, van Duijn E, Fernandez-Bobadilla R, Carceller M, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Ruiz-Idiago J, Sampedro F, Landwehrmeyer GB, Kulisevsky J (2016) Neuropsychiatric symptoms are very common in premanifest and early stage Huntington\u2019s Disease. Parkinsonism Relat Disord 25:58\u201364","journal-title":"Parkinsonism Relat Disord"},{"key":"2794_CR80","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11682-019-00237-x","volume":"15","author":"S Martinez-Horta","year":"2021","unstructured":"Martinez-Horta S, Sampedro F, Horta-Barba A, Perez-Perez J, Pagonabarraga J, Gomez-Anson B, Kulisevsky J (2021) Structural brain correlates of irritability and aggression in early manifest Huntington\u2019s disease. Brain Imaging Behav 15:107\u2013113","journal-title":"Brain Imaging Behav"},{"key":"2794_CR81","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/mds.27395","volume":"33","author":"S Mart\u00ednez-Horta","year":"2018","unstructured":"Mart\u00ednez-Horta S, Perez-Perez J, Sampedro F, Pagonabarraga J, Horta-Barba A, Carceller-Sindreu M, Gomez-Anson B, Lozano-Martinez GA, Lopez-Mora DA, Camacho V, Fern\u00e1ndez-Le\u00f3n A, Carri\u00f3 I, Kulisevsky J (2018) Structural and metabolic brain correlates of apathy in Huntington\u2019s disease. Mov Disord 33:1151\u20131159","journal-title":"Mov Disord"},{"key":"2794_CR82","doi-asserted-by":"publisher","first-page":"993357","DOI":"10.3389\/fnins.2022.993357","volume":"16","author":"DJ McLauchlan","year":"2022","unstructured":"McLauchlan DJ, Linden DEJ, Rosser AE (2022) Excessive response to provocation rather than disinhibition mediates irritable behaviour in Huntington\u2019s disease. Front Neurosci 16:993357","journal-title":"Front Neurosci"},{"key":"2794_CR83","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/mds.26675","volume":"31","author":"TA Mestre","year":"2016","unstructured":"Mestre TA, van Duijn E, Davis AM, Bachoud-L\u00e9vi AC, Busse M, Anderson KE, Ferreira JJ, Mahlknecht P, Tumas V, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P (2016) Rating scales for behavioral symptoms in Huntington\u2019s disease: Critique and recommendations. Mov Disord 31:1466\u20131478","journal-title":"Mov Disord"},{"key":"2794_CR84","doi-asserted-by":"publisher","first-page":"e02151","DOI":"10.1002\/brb3.2151","volume":"11","author":"S Migliore","year":"2021","unstructured":"Migliore S, D\u2019Aurizio G, Maffi S, Ceccarelli C, Ristori G, Romano S, Castaldo A, Mariotti C, Curcio G, Squitieri F (2021) Cognitive and behavioral associated changes in manifest Huntington disease: a retrospective cross-sectional study. Brain Behav 11:e02151","journal-title":"Brain Behav"},{"key":"2794_CR85","doi-asserted-by":"publisher","first-page":"825532","DOI":"10.3389\/fpsyt.2021.825532","volume":"12","author":"MJ Molnar","year":"2022","unstructured":"Molnar MJ, Molnar V, Fedor M, Csehi R, Acsai K, Borsos B, Grosz Z (2022) Improving mood and cognitive symptoms in Huntington\u2019s disease with cariprazine treatment. Front Psychiatry 12:825532","journal-title":"Front Psychiatry"},{"key":"2794_CR86","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/brain\/awab367","volume":"145","author":"A Nair","year":"2022","unstructured":"Nair A, Razi A, Gregory S, Rutledge RB, Rees G, Tabrizi SJ (2022) Imbalanced basal ganglia connectivity is associated with motor deficits and apathy in Huntington\u2019s disease. Brain 145:991\u20131000","journal-title":"Brain"},{"key":"2794_CR87","doi-asserted-by":"crossref","unstructured":"Neueder A, Kojer K, Gu Z, Wang Y, Hering T, Tabrizi S, Taanman JW, Orth M (2024) Huntington disease affects mitochondrial network dynamics predisposing to pathogenic mtDNA mutations. Brain 147:2009\u20132022","DOI":"10.1093\/brain\/awae007"},{"key":"2794_CR88","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuroscience.2012.05.043","volume":"251","author":"J Nithianantharajah","year":"2013","unstructured":"Nithianantharajah J, Hannan AJ (2013) Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington\u2019s disease. Neuroscience 251:66\u201374","journal-title":"Neuroscience"},{"key":"2794_CR89","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/jnnp-2012-304558","volume":"85","author":"C O\u2019Callaghan","year":"2014","unstructured":"O\u2019Callaghan C, Bertoux M, Hornberger M (2014) Beyond and below the cortex: the contribution of striatal dysfunction to cognition and behaviour in neurodegeneration. J Neurol Neurosurg Psychiatry 85:371\u2013378","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2794_CR90","doi-asserted-by":"publisher","first-page":"111023","DOI":"10.1016\/j.jpsychores.2022.111023","volume":"162","author":"AC Ogilvie","year":"2022","unstructured":"Ogilvie AC, Carnahan RM, Chrischilles EA, Schultz JL (2022) The effects of antidepressants on depressive symptoms in manifest Huntington\u2019s disease. J Psychosom Res 162:111023","journal-title":"J Psychosom Res"},{"key":"2794_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JHD-180335","volume":"8","author":"M Oosterloo","year":"2019","unstructured":"Oosterloo M, Craufurd D, Nijsten H, van Duijn E (2019) Obsessive-compulsive and perseverative behaviors in Huntington\u2019s disease. J Huntingtons Dis 8:1\u20137","journal-title":"J Huntingtons Dis"},{"key":"2794_CR92","first-page":"216","volume":"15","author":"T Patzold","year":"2002","unstructured":"Patzold T, Br\u00fcne M (2002) Obsessive compulsive disorder in Huntington disease: a case of isolated obsessions successfully treated with sertraline. Neuropsychiatry Neuropsychol Behav Neurol 15:216\u2013219","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"2794_CR93","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.nbd.2005.10.009","volume":"22","author":"B Picconi","year":"2006","unstructured":"Picconi B, Passino E, Sgobio C, Bonsi P, Barone I, Ghiglieri V, Pisani A, Bernardi G, Ammassari-Teule M, Calabresi P (2006) Plastic and behavioral abnormalities in experimental Huntington\u2019s disease: a crucial role for cholinergic interneurons. Neurobiol Dis 22:143\u2013152","journal-title":"Neurobiol Dis"},{"key":"2794_CR94","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/hbm.24790","volume":"41","author":"L Pini","year":"2020","unstructured":"Pini L, Jacquemot C, Cagnin A, Meneghello F, Semenza C, Mantini D, Vallesi A (2020) Aberrant brain network connectivity in presymptomatic and manifest Huntington\u2019s disease: a systematic review. Hum Brain Mapp 41:256\u2013269","journal-title":"Hum Brain Mapp"},{"key":"2794_CR95","doi-asserted-by":"publisher","first-page":"100482","DOI":"10.1016\/j.bbih.2022.100482","volume":"23","author":"M Podlacha","year":"2022","unstructured":"Podlacha M, Pierzynowska K, Gaffke L, Jerzemowska G, Piotrowska E, Wegrzyn G (2022) Behavioral- and blood-based biomarkers for Huntington\u2019s disease: studies on the R6\/1 mouse model with prospects for early diagnosis and monitoring of the disease. Brain Behav Immun Health 23:100482","journal-title":"Brain Behav Immun Health"},{"key":"2794_CR96","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neures.2021.08.003","volume":"174","author":"B Purushothaman","year":"2022","unstructured":"Purushothaman B, Sumathi T (2022) 5,6,7 trihydroxy flavone armoured neurodegeneration caused by quinolinic acid induced Huntington\u2019s like disease in rat striatum - reinstating the level of brain neurotrophins with special reference to cognitive-socio behaviour, biochemical and histopathological aspects. Neurosci Res 174:25\u201335","journal-title":"Neurosci Res"},{"key":"2794_CR97","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000537750","volume":"16","author":"C Rahn","year":"2024","unstructured":"Rahn C, Peterson K, Lamb E (2024) Repetitive transcranial magnetic stimulation for major depressive disorder in Huntington disease patient with improvement in neuropsychiatric and movement symptoms: a case report. Case Rep Neurol 16:79\u201384","journal-title":"Case Rep Neurol"},{"key":"2794_CR98","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbi.2016.07.004","volume":"58","author":"J Raper","year":"2016","unstructured":"Raper J, Bosinger S, Johnson Z, Tharp G, Moran SP, Chan AWS (2016) Increased irritability, anxiety, and immune reactivity in transgenic Huntington\u2019s disease monkeys. Brain Behav Immun 58:181\u2013190","journal-title":"Brain Behav Immun"},{"key":"2794_CR99","doi-asserted-by":"publisher","first-page":"e0168556","DOI":"10.1371\/journal.pone.0168556","volume":"12","author":"I Rattray","year":"2017","unstructured":"Rattray I, Smith EJ, Crum WR, Walker TA, Gale R, Bates GP, Modo M (2017) Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the HdhQ150\/Q150 mouse model of Huntington\u2019s disease. PLoS ONE 12:e0168556","journal-title":"PLoS ONE"},{"key":"2794_CR100","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3233\/JHD-180325","volume":"8","author":"L Rieke","year":"2019","unstructured":"Rieke L, Fels M, Schubert R, Habbel B, Matheis T, Schuldenzucker V, Kemper N, Reilmann R (2019) Activity behaviour of minipigs transgenic for the Huntington gene. J Huntingtons Dis 8:23\u201331","journal-title":"J Huntingtons Dis"},{"key":"2794_CR101","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbr.2009.04.034","volume":"203","author":"O Rudenko","year":"2009","unstructured":"Rudenko O, Tkach V, Berezin V, Bock E (2009) Detection of early behavioral markers of Huntington\u2019s disease in R6\/2 mice employing an automated social home cage. Behav Brain Res 203:188\u2013199","journal-title":"Behav Brain Res"},{"key":"2794_CR102","doi-asserted-by":"publisher","first-page":"105228","DOI":"10.1016\/j.parkreldis.2022.11.020","volume":"106","author":"J Ruiz-Idiago","year":"2023","unstructured":"Ruiz-Idiago J, Pomarol-Clotet E, Salvador R (2023) Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington\u2019s disease patients. Parkinsonism Relat Disord 106:105228","journal-title":"Parkinsonism Relat Disord"},{"key":"2794_CR103","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s42466-023-00285-1","volume":"5","author":"C Saft","year":"2023","unstructured":"Saft C, Burgunder JM, Dose M, Jung HH, Katzenschlager R, Priller J, Nguyen HP, Reetz K, Reilmann R, Seppi K, Landwehrmeyer GB (2023) Symptomatic treatment options for Huntington\u2019s disease (guidelines of the German neurological society). Neurol Res Pract 5:61","journal-title":"Neurol Res Pract"},{"key":"2794_CR104","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00062-022-01150-5","volume":"32","author":"F Sampedro","year":"2022","unstructured":"Sampedro F, Mart\u00ednez-Horta S, P\u00e9rez-P\u00e9rez J, P\u00e9rez-Gonz\u00e1lez R, Horta-Barba A, Campolongo A, Izquierdo C, Aracil-Bola\u00f1os I, Rivas E, Puig-Davi A, Pagonabarraga J, G\u00f3mez-Ans\u00f3n B, Kulisevsky J (2022) Plasma TDP-43 reflects cortical neurodegeneration and correlates with neuropsychiatric symptoms in Huntington\u2019s disease. Clin Neuroradiol 32:1077\u20131085","journal-title":"Clin Neuroradiol"},{"key":"2794_CR105","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainres.2003.09.049","volume":"994","author":"JA Saydoff","year":"2003","unstructured":"Saydoff JA, Liu LS, Garcia RA, Hu Z, Li D, von Borstel RW (2003) Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington\u2019s disease. Brain Res 994:44\u201354","journal-title":"Brain Res"},{"key":"2794_CR106","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bbr.2003.10.021","volume":"152","author":"ML Scattoni","year":"2004","unstructured":"Scattoni ML, Valanzano A, Popoli P, Pezzola A, Reggio R, Calamandrei G (2004) Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington\u2019s disease. Behav Brain Res 152:375\u2013383","journal-title":"Behav Brain Res"},{"key":"2794_CR107","doi-asserted-by":"publisher","unstructured":"Shafie A, Ashour AA, Anwar S, Anjum F, Hassan MI (2024) Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington\u2019s disease. Arch Pharm Res. doi:https:\/\/doi.org\/10.1007\/s12272-12024-01499-w","DOI":"10.1007\/s12272-12024-01499-w"},{"key":"2794_CR108","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s11011-018-0297-0","volume":"33","author":"A Sidhu","year":"2018","unstructured":"Sidhu A, Diwan V, Kaur H, Bhateja D, Singh CK, Sharma S, Padi SSV (2018) Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model of Huntington\u2019s disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway. Metab Brain Dis 33:1911\u20131921","journal-title":"Metab Brain Dis"},{"key":"2794_CR109","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jns.2009.02.366","volume":"281","author":"AM Smith","year":"2009","unstructured":"Smith AM, Walker LA, Freedman MS, DeMeulemeester C, Hogan MJ, Cameron I (2009) fMRI investigation of disinhibition in cognitively impaired patients with multiple sclerosis. J Neurol Sci 281:58\u201363","journal-title":"J Neurol Sci"},{"key":"2794_CR110","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1089\/jpm.2022.0160","volume":"26","author":"LL Sokol","year":"2023","unstructured":"Sokol LL, Troost JP, Bega D, Paulsen JS, Kluger BM, Applebaum AJ, Frank S, Nance MA, Anderson KE, Perlmutter JS, Depp CA, Grafman J, Cella D, Carlozzi NE (2023) Death anxiety in Huntington disease: longitudinal heath-related quality-of-life outcomes. J Palliat Med 26:907\u2013914","journal-title":"J Palliat Med"},{"key":"2794_CR111","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.3390\/cells11213381","volume":"11","author":"Y Sun","year":"2022","unstructured":"Sun Y, Tong H, Yang T, Liu L, Li XJ, Li S (2022) Insights into white matter defect in Huntington\u2019s disease. Cells 11:3381","journal-title":"Cells"},{"key":"2794_CR112","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1176\/jnp.14.1.37","volume":"14","author":"JC Thompson","year":"2002","unstructured":"Thompson JC, Snowden JS, Craufurd D, Neary D (2002) Behavior in Huntington\u2019s disease: dissociating cognition-based and mood-based changes. J Neuropsychiatry Clin Neurosci 14:37\u201343","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2794_CR113","doi-asserted-by":"publisher","first-page":"RRN1241","DOI":"10.1371\/currents.RRN1241","volume":"3","author":"AL Vaccarino","year":"2011","unstructured":"Vaccarino AL, Anonymous, Anderson KE, Borowsky B, Coccaro E, Craufurd D, Endicott J, Giuliano J, Groves M, Guttman M, Ho AK, Kupchak P, Paulsen JS, Stanford MS, van Kammen DP, Watson D, Wu KD, Evans K (2011) Assessing behavioural manifestations prior to clinical diagnosis of Huntington disease: anger and irritability and obsessions and compulsions. PLoS Curr 3:RRN1241","journal-title":"PLoS Curr"},{"key":"2794_CR114","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/hbm.22799","volume":"36","author":"J Van den Stock","year":"2015","unstructured":"Van den Stock J, De Winter FL, Ahmad R, Sunaert S, Van Laere K, Vandenberghe W, Vandenbulcke M (2015) Functional brain changes underlying irritability in premanifest Huntington\u2019s disease. Hum Brain Mapp 36:2681\u20132690","journal-title":"Hum Brain Mapp"},{"key":"2794_CR117","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/B978-0-12-801893-4.00011-0","volume":"144","author":"E van Duijn","year":"2017","unstructured":"van Duijn E (2017) Medical treatment of behavioral manifestations of Huntington disease. Handb Clin Neurol 144:129\u2013139","journal-title":"Handb Clin Neurol"},{"key":"2794_CR115","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","volume":"85","author":"E van Duijn","year":"2014","unstructured":"van Duijn E, Craufurd D, Hubers AA, Giltay EJ, Bonelli R, Rickards H, Anderson KE, van Walsem MR, van der Mast RC, Orth M, Landwehrmeyer GB (2014a) Neuropsychiatric symptoms in a European Huntington\u2019s disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry 85:1411\u20131418","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2794_CR116","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000343210","volume":"13","author":"E van Duijn","year":"2014","unstructured":"van Duijn E, Reedeker N, Giltay EJ, Eindhoven D, Roos RA, van der Mast RC (2014b) Course of irritability, depression and apathy in Huntington\u2019s disease in relation to motor symptoms during a two-year follow-up period. Neurodegener Dis 13:9\u201316","journal-title":"Neurodegener Dis"},{"key":"2794_CR118","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"2794_CR119","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1097\/YCT.0000000000000961","volume":"40","author":"PY Wang","year":"2024","unstructured":"Wang PY, Lin CH, Yang WC (2024) Electroconvulsive therapy for obsessive and compulsive symptoms in preclinical Huntington disease: a case report. J ECT 40:e3\u2013e4","journal-title":"J ECT"},{"key":"2794_CR120","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuro.2021.09.002","volume":"87","author":"JM Wilcox","year":"2021","unstructured":"Wilcox JM, Pfalzer AC, Tienda AA, Debbiche IF, Cox EC, Totten MS, Erikson KM, Harrison FE, Bowman AB (2021) YAC128 mouse model of Huntington disease is protected against subtle chronic manganese (Mn)-induced behavioral and neuropathological changes. Neurotoxicology 87:94\u2013105","journal-title":"Neurotoxicology"},{"key":"2794_CR121","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JHD-140132","volume":"4","author":"NI Wood","year":"2015","unstructured":"Wood NI, Morton AJ (2015) Social behaviour is impaired in the R6\/2 mouse model of Huntington\u2019s disease. J Huntingtons Dis 4:61\u201373","journal-title":"J Huntingtons Dis"},{"key":"2794_CR122","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/hmg\/ddw077","volume":"25","author":"DJ Wright","year":"2016","unstructured":"Wright DJ, Gray LJ, Finkelstein DI, Crouch PJ, Pow D, Pang TY, Li S, Smith ZM, Francis PS, Renoir T, Hannan AJ (2016) N-acetylcysteine modulates glutamatergic dysfunction and depressive behavior in Huntington\u2019s disease. Hum Mol Genet 25:2923\u20132933","journal-title":"Hum Mol Genet"},{"key":"2794_CR123","doi-asserted-by":"publisher","first-page":"e0164072","DOI":"10.1371\/journal.pone.0164072","volume":"11","author":"E Yhnell","year":"2016","unstructured":"Yhnell E, Dunnett SB, Brooks SP (2016) A longitudinal operant assessment of cognitive and behavioural changes in the HdhQ111 mouse model of Huntington\u2019s disease. PLoS ONE 11:e0164072","journal-title":"PLoS ONE"},{"key":"2794_CR124","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/jcbfm.2011.157","volume":"32","author":"L Zacharoff","year":"2012","unstructured":"Zacharoff L, Tkac I, Song Q, Tang C, Bolan PJ, Mangia S, Henry PG, Li T, Dubinsky JM (2012) Cortical metabolites as biomarkers in the R6\/2 model of Huntington\u2019s disease. J Cereb Blood Flow Metab 32:502\u2013514","journal-title":"J Cereb Blood Flow Metab"},{"key":"2794_CR125","doi-asserted-by":"crossref","unstructured":"Zadegan SA, Ramirez F, Reddy KS, Sahin O, Rocha NP, Teixeira AL, Furr Stimming E (2024) Treatment of depression in Huntington\u2019s disease: a systematic review. J Neuropsychiatry Clin: https:\/\/neuro.psychiatryonline.org\/doi\/full\/10.1176\/appi.neuropsych.20230120","DOI":"10.1176\/appi.neuropsych.20230120"},{"key":"2794_CR126","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.parkreldis.2018.01.006","volume":"49","author":"D Zielonka","year":"2018","unstructured":"Zielonka D, Ren M, De Michele G, Roos RAC, Squitieri F, Bentivoglio AR, Marcinkowski JT, Landwehrmeyer GB (2018) The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington\u2019s disease. Parkinsonism Relat Disord 49:42\u201347","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02794-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-024-02794-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-024-02794-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T18:02:33Z","timestamp":1725127353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-024-02794-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":126,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2794"],"URL":"https:\/\/doi.org\/10.1007\/s00702-024-02794-y","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}